 

TCGA- CC- A7IE- OIA- PR

Ill
llllllllllllllIIlllllllllllllll||||||||||||||||||||H|||||||| Fem Revised '
|||||||||||||||||||||||||l|||||||||||||||||l|l|||||||||||I|||||| Fa}:- ’" " "a”

Clinical Case Report

'0 r 3
(For Collection of Cancerous Tissua . 173D
‘ / ‘ Ki 1 E L

0254.“ 052$? 5
SJ; (9%) Joins/15

uum: zssams- 903- ms- szsa- DBQEBB4RCAe545c
I 19.3 APPROVED

 

 

{Informed Consenj

 

I personally informed this patient that 3. Specimens) would be collected to be used for research
purposes. I reviewed the SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at
our institution.

 

blame of Physician or Study Co'ordinatorﬁ ' mgnarure Date

 

Elinical Information]

GENERAL N
of BM!- ’mmlddl‘m‘ ﬂ

Gender , Blood Pressure Heart Rate
Male Cl Female

 

 

HISTORY OF PRESENT ILLNESS

 

ChiefComplaints: Abdlmwquﬁ [7504 r/ 9W 11‘ wt (/21 «em/[Mb

 

Symptoms: \l/ a @M (/09;

 

Clinical Findings:

 

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic 1:: 80-90 Symptomatic but Fully Ambulatory a 60-70 Symptomatic,‘ in bed less than 50% of day
)mo- 50 Symptomatic in bed more than 50% of day, but not bed ridden I: 20-30 Bed Ridden

 

 

CURRENT MEDICATIONS
Dose

 

PAST MEDICAL HISTORY
Disorder

Date

 

 

 

 

 

 

OB/GYN HISTORY .
Menopausal Stable Date of First Menses # of Pregnancies
Cl Pro-menopausal
[:1 Peri-Menopausal Date of Last Menses # of Live Births
E] Post-mempausal

 

 

Birth Control: El Condom Cl Oral Conuaceptive
CI Other:

:1 IUD D Hormone Replacement

Therapy:

 

 

 

SOCIAL HISTORY
Hazards:
H
Current Status
U YES NO

Duration

Alcohol Consum

YES :1 NO *
Use

FAMILY MEDICAL

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA

Test Result l Date l _ 1 Test Result oats
HIV Weﬁetive t] Positive: _ CEA El Negative El Positive:

Hep B #1 Negative (3 Positive: CA 15-33 C! Negative Cl Positive:

Hep C ~33! Negative Cl Positive: CA 19-9 El Negative t] Positive:
AFP t: Negative U Positive: PSA {3 Negative El Positive:

Other: E] Negative Cl Positive: Other: Cl Negative Cl Positive:

Bfi‘ Cell Markers:

 

 

DIAGNOSTIC STUDIES

Ultrasound
x.
CT

MRI
B

CLINICAL DIAGNOSIS
We use

Involved L Nodes Distant

Date of Dlaonosls

M4,: Stage: 2214‘

[Treatment Information!
SURGICAL TMENT

 

 

 

Pri

Paipable, Non-Dissected Lymph Nodes
Dissected Lymph Nodes

Distant Metastasis

Location

 

Pathology Form

 

iSpecimen Information]

 

 

 

 

 

 

 

 

 

 

 

Collected by: V, Date: JTime;
Preserved by: __ Dat' ’ ‘Time;
SPECIMEN TYPE (# of samples provided)
Frozen Parafﬁn Block Blood/Serum/Plasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
2— 2$“ 2." A 2.
’ Time to LN2 Time to Formalin Time to ma -
min min min

 

 

 

 

 

 

 

 

 

PATHOLOGICAL DESCRIPTION

Tumor
Slza Distance to NAT

F...

x x cm ‘ cm
L Nodes-

Distant Metastasis

 

IRE APPROVED

 

 

“592mm 5
Tel Fax: ‘

Consolidated Pathology Diagnosis

Cellular Differentiation: :1 Well

 

Nuclear Grade:

 

{ﬁnal Pathology Roma

Histological Diagnmk:ﬂ7/%MWGH®= _2_=

Wﬁmw WW WW v V

 

f

 

 

 

. Date
Director, Research Pathology

Criteria

INTEGRATED REPORT OF FINDINGS BY COLLABORATORS AND RTHOLOGISTS -— " ”“5"“

HIPAA
an

 

Case is
Reviewer lnm‘als

 

